Image Place holder

Amr Mohamed, MD


Specialty: Medical Oncology
Program: Gastrointestinal Oncology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)

Overview

Cancer Types Treated: Gallbladder Cancer , Liver Cancer , Neuroendocrine Tumor , Pancreatic Cancer , Stomach (Gastric) Cancer , Colorectal Cancer , Esophageal Cancer

Dr. Mohamed earned his MD degree at Cairo University School of Medicine, Cairo, Egypt and completed a post-doctoral Research Fellowship in Medical Oncology at Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia. Dr. Mohamed completed an Internal Medicine Residency at Morehouse School of Medicine, Atlanta, Georgia and recently completed a Medical Oncology Fellowship at Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. Dr. Mohamed’s clinical interest is in neuroendocrine tumors and colorectal cancer. His research focus is on clinical outcomes and clinical trials, including Phase 1 studies.

Education & Training

Board Certification:

  • Internal Medicine

Fellowship:

  • Karmanos Cancer Institute, Wayne State University - Medical Oncology
  • Emory University School of Medicine - Research Fellowship

Residency:

  • Morehouse School of Medicine - Internal Medicine

Medical School:

  • Cairo University School of Medicine - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Mohamed A, Twardy B, AbdAllah N, Akhras A, Ismail H, Zordok M, Schrapp K, Attumi T, Tesfaye A, El-Rayes B. Clinical Impact of PI3K/BRAF Mutations in RAS Wild Metastatic Colorectal Cancer: Meta-analysis Results. J Gastrointest Cancer. 2018 Feb. Pubmedid: 29388061.
  • Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ. Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. Ann Surg Oncol. 2017 Nov;24(12):3667-3672. Pubmedid: 28831698.
  • Mohamed A, Chenna A, Abdelfatah M, Sanjay J, Mohammad MK, Saber I, Kauh J, Elhammali B, Kaseb A. Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma. J Gastrointest Cancer. 2015 Jun;46(2):104-108. Pubmedid: 25645584.
  • Mohamed A, Ayman A, Deniece J, Wang T, Kovach C, Siddiqui MT, Cohen C. P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas. Front Oncol. 2015;5:70. Pubmedid: 25870850. Pmcid: PMC4378280.
  • Mohamed A, Deng X, Khuri FR, Owonikoko TK. Altered glutamine metabolism and therapeutic opportunities for lung cancer. Clin Lung Cancer. 2014 Jan;15(1):7-15. Pubmedid: 24377741. Pmcid: PMC3970234.
  • Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications. Appl Immunohistochem Mol Morphol. 2014 Feb;22(2):142-145. Pubmedid: 23958542.
  • Mohamed A, El-Rayes B, Khuri FR, Saba NF. Targeted therapies in metastatic esophageal cancer: advances over the past decade. Crit Rev Oncol Hematol. 2014 Aug;91(2):186-196. Pubmedid: 24582516.
  • Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C. SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):506-510. Pubmedid: 23197006.
  • Hosny Mohammed K, Siddiqui MT, Willis BC, Zaharieva Tsvetkova D, Mohamed A, Patel S, Sharma J, Weber C, Cohen C. Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas. Appl Immunohistochem Mol Morphol. 25(10):731-735. Pubmedid: 27490759.